← Leaderboards
Marie-Louise Hammarskjold
University Of Virginia
$8,275,607
Attributed
$10,683,532
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $726K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,683,532 · 12
By mechanism
R01$8,357,764 · 6
R21$2,325,768 · 6
Top collaborators
- David M Rekosh16 shared
Most similar at University Of Virginia
Same institution · by research overlap
- David M Rekosh$6,031,711
- Patrick Evan Hager Jackson$1,452,000
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsPlayElementsMessenger RnaMediatingBaseVirusTranslationsIntronsResearch StudyLeadGenesAffectHiv InfectionsGene ExpressionPublishingRna SplicingPublicationsStructureViralBindingRegulationMutation
Grant awards (38)
Host Factors That Restrict HIV mRNA With Retained Introns$161,500
R21 · FY2023 · AI · contact PI
Effects of HIV Rev on Host Cell Gene Expression$161,500
R21 · FY2023 · AI
Effects of HIV Rev on Host Cell Gene Expression$282,625
R21 · FY2022 · AI
Host Factors That Restrict HIV mRNA With Retained Introns$282,625
R21 · FY2022 · AI · contact PI
HIV, HERV-K and Human Cancer$403,750
R01 · FY2021 · CA · contact PI
HIV, HERV-K and Human Cancer$403,750
R01 · FY2020 · CA · contact PI
HIV, HERV-K and Human Cancer$509,230
R01 · FY2019 · CA · contact PI
HIV, HERV-K and Human Cancer$524,710
R01 · FY2018 · CA · contact PI
Role of HIV Rev in Reactivation from Latency$201,250
R21 · FY2018 · AI
HIV, HERV-K and Human Cancer$401,250
R01 · FY2017 · CA · contact PI
Role of HIV Rev in Reactivation from Latency$241,500
R21 · FY2017 · AI
Functional Variation of Rev and RRE Activity During HIV Infection$298,040
R01 · FY2016 · GM · contact PI
Functional Variation of Rev and RRE Activity During HIV Infection$298,040
R01 · FY2015 · GM · contact PI
Functional Variation of Rev and RRE Activity During HIV Infection$298,040
R01 · FY2014 · GM · contact PI
HIV and ADAR Editing$158,000
R21 · FY2014 · AI · contact PI
Functional Variation of Rev and RRE Activity During HIV Infection$50,000
R01 · FY2014 · GM · contact PI
Functional Variation of Rev and RRE Activity During HIV Infection$298,040
R01 · FY2013 · GM · contact PI
HIV and ADAR Editing$273,658
R21 · FY2013 · AI · contact PI
NXF Proteins, Cofactors and Targets$296,970
R01 · FY2012 · GM · contact PI
NXF Proteins, Cofactors and Targets$296,970
R01 · FY2011 · GM · contact PI
NXF Proteins, Cofactors and Targets$299,970
R01 · FY2010 · GM · contact PI
Therapeutic Antisense RNA and The HIV Rev-RRE Pathway$149,985
R21 · FY2010 · AI · contact PI
NXF Proteins, Cofactors and Targets$303,000
R01 · FY2009 · GM · contact PI
Therapeutic Antisense RNA and The HIV Rev-RRE Pathway$265,125
R21 · FY2009 · AI · contact PI
Sam 68 and the Function of Mason Pfizer Monkey Virus CTE$287,176
R01 · FY2007 · CA · contact PI
HIV Rev Function$279,330
R01 · FY2007 · AI · contact PI
Sam 68 and the Function of Mason Pfizer Monkey Virus CTE$295,824
R01 · FY2006 · CA · contact PI
HIV Rev Function$287,726
R01 · FY2006 · AI · contact PI
Sam 68 and the Function of Mason Pfizer Monkey Virus CTE$303,015
R01 · FY2005 · CA
HIV Rev Function$294,702
R01 · FY2005 · AI
Sam 68 and the Function of Mason Pfizer Monkey Virus CTE$302,268
R01 · FY2004 · CA
HIV Rev Function$294,752
R01 · FY2004 · AI
Sam 68 and the Function of Mason Pfizer Monkey Virus CTE$302,171
R01 · FY2003 · CA
HIV Rev Function$294,800
R01 · FY2003 · AI
REGULATION OF HIV RNA PROCESSING AND TRANSPORT$252,017
R01 · FY2002 · AI
REGULATION OF HIV RNA PROCESSING AND TRANSPORT$244,675
R01 · FY2001 · AI
REGULATION OF HIV RNA PROCESSING AND TRANSPORT$237,548
R01 · FY2000 · AI
DEVELOPMENT OF IMMUNE MODULATORY VIRAL VECTORS$148,000
R21 · FY2000 · DK